Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Functional inactivation of the tumor suppressor p27(kip1) in human cancer occurs either through loss of expression or through phosphorylation-dependent cytoplasmic sequestration. Here we demonstrate that dysregulation of the PI3K/AKT pathway is important in thyroid carcinogenesis and that p27(kip1) is a key target of the growth-regulatory activity exerted by this pathway in thyroid cancer cells. Using specific PI3K inhibitors (LY294002, wortmannin, and PTEN) and a dominant active AKT construct (myrAKT), we demonstrated that the PI3K/AKT pathway controlled thyroid cell proliferation by regulating the expression and subcellular localization of p27. Results obtained with phospho-specific antibodies and with transfection of nonphosphorylable p27(kip1) mutant constructs demonstrated that PI3K/AKT-dependent regulation of p27(kip1) mislocalization in thyroid cancer cells occurred via phosphorylation of p27(kip1) at T157 and T198 (but not at S10 or T187). Finally, we evaluated whether these results were applicable to human tumors. Analysis of 100 thyroid carcinomas indicated that p27(kip1) phosphorylation at T157/T198 and cytoplasmic mislocalization were preferentially associated with activation of the PI3K/AKT pathway. Thus the PI3/AKT pathway and its effector p27(kip1) play major roles in thyroid carcinogenesis.
Motti
Maria Letizia
ML
Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Università di Napoli Federico II, via S. Pansini 5, 80131 Napoli, Italy.
Califano
Daniela
D
Troncone
Giancarlo
G
De Marco
Carmela
C
Migliaccio
Ilenia
I
Palmieri
Emiliano
E
Pezzullo
Luciano
L
Palombini
Lucio
L
Fusco
Alfredo
A
Viglietto
Giuseppe
G
D000730:Androstadienes / Q000494:pharmacology; D015153:Blotting, Western; D001973:Bromodeoxyuridine / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000096:biosynthesis* / Q000378:metabolism; D045744:Cell Line, Tumor; D002867:Chromones / Q000494:pharmacology; D050760:Cyclin-Dependent Kinase Inhibitor p27; D003593:Cytoplasm / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004789:Enzyme Activation; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008856:Microscopy, Fluorescence; D009025:Morpholines / Q000494:pharmacology; D051059:PTEN Phosphohydrolase; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D020133:Reverse Transcriptase Polymerase Chain Reaction; D044786:S-Phase Kinase-Associated Proteins / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000378:metabolism*; D013997:Time Factors; D014162:Transfection; D025521:Tumor Suppressor Proteins / Q000096:biosynthesis* / Q000378:metabolism; D000077191:Wortmannin
D000730:Androstadienes; D001973:Bromodeoxyuridine; D018797:Cell Cycle Proteins; D002867:Chromones; D050760:Cyclin-Dependent Kinase Inhibitor p27; D009025:Morpholines; D051059:PTEN Phosphohydrolase; D019869:Phosphatidylinositol 3-Kinases; D010744:Phosphoric Monoester Hydrolases; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D044786:S-Phase Kinase-Associated Proteins; D025521:Tumor Suppressor Proteins; D000077191:Wortmannin; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C494918:AKT1 protein, human; C494929:PTEN protein, human
J Natl Cancer Inst. 2003 Apr 16;95(8):625-7
12697856
EMBO J. 1999 Mar 1;18(5):1223-34
10064589
Eur J Endocrinol. 1999 Jan;140(1):94-103
10037258
J Cell Physiol. 2000 Apr;183(1):18-27
10699962
Genes Dev. 1994 Jan;8(1):9-22
8288131
Oncogene. 2000 Jun 29;19(28):3146-55
10918569
Thyroid. 2001 Apr;11(4):339-51
11349832
J Biol Chem. 2000 Dec 15;275(50):39223-30
11010972
Biochim Biophys Acta. 2002 Mar 14;1602(1):73-87
11960696
EMBO J. 2001 Dec 3;20(23):6672-82
11726503
Cancer Res. 2004 Jun 1;64(11):3823-9
15172989
J Med Genet. 2004 Mar;41(3):161-70
14985374
Biochem J. 2000 Jun 1;348 Pt 2:351-8
10816429
Nat Med. 2002 Oct;8(10):1076-8
12357238
Am J Pathol. 2000 May;156(5):1693-700
10793080
Int J Oncol. 1998 Mar;12(3):701-10
9472113
Science. 1995 Aug 4;269(5224):682-5
7624798
Nat Med. 1997 Feb;3(2):227-30
9018244
J Clin Invest. 1999 Oct;104(7):865-74
10510327
Cell Cycle. 2002 Nov-Dec;1(6):391-3
12548011
J Immunol. 2004 May 1;172(9):5522-7
15100294
Cell Cycle. 2004 Aug;3(8):1074-80
15280662
Mol Cell Biol. 2000 Aug;20(15):5690-9
10891505
Cancer Res. 1998 Apr 15;58(8):1730-5
9563491
Genes Dev. 1999 Jun 15;13(12):1501-12
10385618
J Cell Physiol. 2000 Apr;183(1):10-7
10699961
Nature. 2001 May 17;411(6835):355-65
11357143
Mol Endocrinol. 2002 May;16(5):903-11
11981026
Biochem Biophys Res Commun. 2000 Jul 21;274(1):37-42
10903892
Genes Dev. 1997 Jun 1;11(11):1464-78
9192873
Nature. 2000 Apr 13;404(6779):782-7
10783894
Cell Cycle. 2002 Nov-Dec;1(6):394-400
12548012
Oncogene. 2003 Jul 17;22(29):4578-80
12881714
J Biol Chem. 2002 Aug 9;277(32):28706-13
12042314
Genes Dev. 1999 May 1;13(9):1181-9
10323868
Endocr Pathol. 2002 Spring;13(1):3-16
12114746
Cancer Res. 1997 Aug 15;57(16):3381-5
9270000
Nat Med. 2002 Oct;8(10):1145-52
12244301
Cancer Res. 1999 Aug 1;59(15):3790-4
10446997
Oncogene. 1999 Nov 4;18(46):6241-51
10597222
EMBO J. 2002 Jul 1;21(13):3390-401
12093740
Nat Cell Biol. 1999 Aug;1(4):193-9
10559916
Oncogene. 1992 Dec;7(12):2549-53
1334253
Endocr Rev. 2001 Oct;22(5):631-56
11588145
J Clin Endocrinol Metab. 2003 Sep;88(9):4393-7
12970315
Nat Med. 2002 Oct;8(10):1136-44
12244303
Curr Opin Cell Biol. 1998 Apr;10(2):262-7
9561851
Cancer Res. 1997 Nov 1;57(21):4710-3
9354427
Genes Chromosomes Cancer. 1998 Nov;23(3):239-43
9790504
J Clin Endocrinol Metab. 2003 May;88(5):2318-26
12727991
Science. 1991 Oct 11;254(5029):274-7
1833819
Mol Cell Biol. 2000 Dec;20(24):9138-48
11094066
Cancer Res. 1998 Jan 1;58(1):114-22
9426067
J Immunol. 2002 May 15;168(10):5024-31
11994454
Cancer Res. 2001 Aug 15;61(16):6105-11
11507060
EMBO J. 1997 Sep 1;16(17):5334-44
9311993
Nat Med. 1997 Feb;3(2):231-4
9018245
EMBO J. 2004 May 5;23(9):1934-42
15057270
Science. 1996 Dec 6;274(5293):1672-7
8939849
Nat Med. 2002 Oct;8(10):1153-60
12244302
Genes Dev. 1998 Nov 15;12(22):3499-511
9832503